Primary Biliary Cirrhosis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue; Primary Biliary CirrhosisInterventions: Biological: Rituximab; Other: PlaceboSponsors: Newcastle-upon-Tyne Hospitals NHS Trust; National Institute for Health Research, United Kingdom; Department of Health, United Kingdom; Newcastle UniversityRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2015 Category: Research Source Type: clinical trials
An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: LUM001Sponsor: Lumena Pharmaceuticals, Inc.Not yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2014 Category: Research Source Type: clinical trials
An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: LUM001Sponsor: Lumena Pharmaceuticals, Inc.Not yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2014 Category: Research Source Type: clinical trials
